Navigating ADC Development: Regulatory Landscape, Laboratory Readiness & Containment Challenges
24 Sep, 2026 3:00 PM - 4:00 PM CEST
Discover how to navigate the evolving ADC landscape with confidence. This webinar covers regulatory expectations, HPAPI containment, laboratory readiness, and practical lessons learned from supporting ADC development programs, helping you reduce risk and streamline development.
Speakers:
Felix Harion – Scientific Expert, Business Development Manager, Eurofins BioPharma Product Testing Germany
Francesco Cianciulli - Health, Safety & Environment Senior Specialist – Eurofins BioPharma Product Testing Italy
Antibody-drug conjugates (ADCs) are among the fastest-growing and most complex therapeutic modalities. As pipelines evolve towards increasingly potent payloads and next-generation formats, developers face growing regulatory expectations and significant operational challenges. Beyond analytical expertise, successful ADC programs require laboratories that are fully prepared to safely handle highly potent compounds while generating robust, regulator-ready data.
In this webinar, Eurofins BPT experts will discuss the current ADC landscape, evolving regulatory expectations, HPAPI containment principles and the key considerations for ensuring laboratory readiness throughout development.
Key topics include:
- The evolving ADC landscape and regulatory expectations
- HPAPI risk categories and containment considerations
- Laboratory readiness for ADC testing
- Infrastructure, equipment and sample handling best practices
- Lessons learned from supporting ADC development programs
Join us to discover how early planning and the right laboratory strategy can help reduce risk, streamline development and support successful ADC programs.
📅 Date: 24 Sep 2026
⏰ Time: 3:00 PM - 4:00 PM CEST